chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt felt faint, looked pale had bp about 90/60 (although she indicated her bp was usually low).  She also reports this happening whenever she gets a vaccination or has blood drawn.  We asked her to sit down, gave her a glass of water.  We requested she sit for 15 minutes, but she refused, stayed 10 minutes and drove to work.  I attempted to call her later that day, but she did not answer nor did she call back.
Achiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Achiness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Achiness at the injection site). At the time of the report, VACCINATION SITE PAIN (Achiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
Patient's arm was red and hot and she got a fever. She went to doctor after 1 week of no relief and he prescribed BACTRIM DS.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. No Treatment information  provided   This case was linked to -MODERNATX, INC.-MOD-2021-057960 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-057960:
Pt recvd vax 25OCT93 & 1 to 2 days later devel soreness & itching @ the site of inject; also exp joint pains in the shoulder, arms & pelvis for 2 wks; 29NOV93 all sx abated;
COVID-19 Vaccine EUA I'm experiencing "COVID arm" symptoms: swelling around the injection site, redness, light itching. It started late on day 8 after the injection. Seems to be getting better today.
6Oct97 pt recv 1 dose vax. 21Jan98 pt devel chickenpox w/10 lesions & mild erythema.
After an hour of  receiving the moderna covid-19 vaccine on February 20th my left arm started burning, The burning sensation hasn't stopped since I got the first dose. In fact it has gotten worse, now my arm feels week, my fingers tingle and the burning sensation radiates to my neck and left ear.  I been to the emergency room, VA clinic, and local clinic and nobody has helped me. Everyone just tells me to take ibuprofen, Tylenol, naproxen, use hot and cold compressions. Nothing has helped, If someone can call me and help me I will really appreciated.
Patient developed blueness around mouth when placed supine after receiving Rotateq. Self resolved when placed upright.
first dose on 21Jan2021 and second dose on 01Feb2021; passed away; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient's wife). A male patient of an unspecified age received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on 01Feb2021, as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) for COVID-19 immunisation and experienced a terrible reaction. The patient passed away (death) on 09Apr2021. It was unknown if an autopsy was performed.  The information on the lot/batch number has been requested.; Reported Cause(s) of Death: passed away
I was very sick after I took COVID 19 (Pfizer) vaccine for 4 days. Leg Cramp, diarrhea, chilling
Patient given 0.3 Ml dose for above 12 years old but is 10 years old.  No adverse events reported.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 21-NOV-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R015432, expiration date 15-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Anaphylaxis (throat closing, tongue swelling and numbness) vasovagal syncope, nausea all occured within 10 minutes of receiving vaccine. Pharmacist did not provide epipen and administered benadryl. Symptoms slowly subsided but then worsened whereas I experienced numbing and tingling in my arms. After calling my allergist to discuss getting an allergist appt as the pharmacist was not able to provide the care I needed because she was busy, the nurse at the allergist advised me to get straight to the ER or Urgent care. I went to the emergency room where I was treated with 60 mg prednisone, pepcid, and filled prescriptions for prednisone and an epipen.   I have completed my prednisone but I continue to feel a severe headache on one side, sore throat, pain in my arm, and extreme fatigue. I would not say that I have recovered at this point.
This spontaneous report as received from a patient's father's friend's friend refers to a 16 year old male patient. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On an unknown date, the patient was vaccinated with GARDASIL 9 injection (dose, route of administration, lot# and expiration date were not provided). It was reported that on an unknown date, the patient developed supraclavicular lymph nodes. The outcome of the adverse event and the relatedness between the adverse event and GARDASIL 9 were not provided. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA011253.
fever of 100.0; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2021, the patient received the 2nd dose of Shingrix. In January 2021, 28 hrs after receiving Shingrix, the patient experienced fever. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication. The patient received the vaccine 28 hours ago from date of reporting and ran into a fever of 100 degree F. The patient took some Tylenol.
AFTER RECEIVING THE FLU SHOT THE PATIENT STARTED HAVING NUMBNESS OF THE MANDIBLE, MOUTH AND TONGUE, AFTERWARD WITH HEADACHE.
Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm was sore) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced MYALGIA (Arm was sore). At the time of the report, MYALGIA (Arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-147966 (Patient Link).
This spontaneous report was received from a pharmacist regarding an approximately 17 years old non-pregnant female patient. It was reported that patient was very healthy and had none drug allergies or reactions. On 19-JUL-2016, the patient was vaccinated with GARDASIL. Patient was on none concomitant medication. The following week on an unknown date in 2016 the patient developed a cough and a hoarse voice and then she had really bad dreams in which she was sitting on the toilet, and she would wet the bed. No treatment was given for the adverse event and she did not seek any medical attention. No laboratory diagnostic tests were performed. The pharmacist reports that these symptoms went away within 7 to 10 days of the onset of these symptoms and the outcome of the events were reported as resolved. Causality was unknown. Additional information has been requested.
About 6 hours after receiving second shot, severe stomach pains that have never been experienced. So bad ended up in emergency room. Morphine was given with little effect to pain, just stopped extreme pains if not moved. Had CAT scans to rule out appendicitis or cysts. Blood work came back fine, nothing found in CAT scan. Was sent home with pain meds. Next day severe itchy all over. 6 days later still swelling where shot was given along with still painful stomach. Was told by our doctor and emergency doctor that the shot does not have these side effect. Website proves different. Are these doctors not informed. Read that 1 in 7 show these signs of reactions. Is it safe to receive last shot? 1 week of pain!
-Patient said his arm hurts, especially when he moves or touches it. His arm is not red, swollen or warm to touch. He said he's been icing it all night, he said the pain is better compared to last night. I recommended patient to take Mortin if needed for the pain and also monitor his symptoms. He will also follow up with his primary care doctor.
paralyzed and that led her to early death; Initial information was received on 19-Nov-2020 regarding an unsolicited valid serious social media case from a non-health professional via social media.  This case was linked with the 2020SA333271 (same reporter).  This case involves a female patient (of an unknown age) who was paralyzed and that led to her early death (paralysis), while the she received INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications, and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer, (lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was paralyzed and that led to early death (paralysis), (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death.  Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the event was fatal.  It was unknown if an autopsy was done. The cause of death was reported as paralysis.  There will be no information available on the batch number for this case.; Sender's Comments: This was a poorly documented social media case received from social media involves a female patient (age unspecified) who was died due to paralysis after vaccination with INFLUENZA VACCINE. The time to onset is unknown. Further information regarding concurrent condition during vaccination, previous vaccination and tolerance, laboratory investigations, autopsy result and other alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.; Reported Cause(s) of Death: paralyzed and that led to early death
7/26/11. Received multiple vaccines. Had cholangeritis two days later, turned blue, and has had now hypotonia. Vaccine on 3/13/12 with acute exacerbation of erythema with eczema.
Red rash at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE PAIN (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 01-Apr-2021, the patient experienced VACCINATION SITE RASH (Red rash at injection site). At the time of the report, VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
11/1 (2 days after injection): noticed hard and tender at site, (L) deltoid; progressed to axillary soreness and gradually developed numbness/tingling in arm and hand. 11/8: "Throbbing pain". 11/3: pain persisted, "skin hurt"; tingling in arm and medial aspect (L) foot. To MD and was given Tylenol with codeine and Cephalexin. 11/6: Symptoms better, not gone, intermittent pain with tingling. Will return to MD if not resolved when medicine completed.
No adverse event; was given to her a few inches towards the back of the arm; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (was given to her a few inches towards the back of the arm) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-Nov-2022, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (was given to her a few inches towards the back of the arm). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (was given to her a few inches towards the back of the arm) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication were reported. Patient received the booster. However, patient did not believe it was given in the deltoid muscle. It was given a few inches towards the back of the arm.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Patient received Moderna as her first primary COVID vaccine on 3/14/2021 at pharmacy (Lot #001B21A per COVID card). Patient then received a primary Pfizer vaccine on 8/12/22 from a different pharmacy (Lot #FC3181 per COIVD card). Patient received Bivalent Moderna booster today. Unable to reach patient after visit to discuss.
Started with lump and redness of the right deltoid within 45 minutes of receiving Pneumovax, condition progressed to right scapula pain which radiated down to just below right elbow followed by redness, edema.  I have not seen reaction, patient called in sick to her place of employment 9/19 and 9/20.  Saw physician, MOTRIN 600 mg three times a day, Loratadine.? Patient returning to medical doctor 9/20/06.
I got a scratchy throat and my head started to hurt. I spiked a fever. This was about 4 days after my son was diagnosed with Covid. He lost his taste and smell, but I did not. I pretty much have just been laying low and chilling out. I have been taking cough medicine and Tylenol for the headache and fever. The fever stopped about 3 days in. It just feels like a bad cold. I have been trying to stay hydrated and I have not really had an appetite. I have had sinus infections that are worse than this. I went to the urgent care center and my test came back negative. I went to pharmacy the next day to get my test redone and that one came back positive.
A little cough with phlegm; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (A little cough with phlegm) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PRODUCTIVE COUGH (A little cough with phlegm). On 31-Jan-2021, PRODUCTIVE COUGH (A little cough with phlegm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states he takes medicine for his blood pressure (not specified), cholesterol (not specified) and also an anti-acid (not specified). No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Patient declined consent for further follow up.
Blood clots (i started heavy menstrual cramps a day after the shot and I saw exceeding amount of blood clots which has never happened this excessively before) Fever, chills, headchae, nausea (all very severe level)
No additional AE information provided; HCP states that ROTATEQ was administered to a patient after temperature excursions; This spontaneous report was received from a pharmacist regarding to a patient of unspecified age and gender. The patient's pertinent medical history, drug reactions and allergies, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #W002561, expiration date: 07-OCT-2023 (dosage regimen was not provided) administered orally as prophylaxis (product storage error).   The improperly stored vaccine dose underwent a temperature excursion for 1 hour at 9.13 degrees Celsius (C), and 37 hours and 15 minutes at minimum of -8.45 C without previous excursions. No adverse events were reported.
Headache day of and next day Breast tenderness the next day Pain and swelling at site next day
Information has been received from a physician concerning a 22 years old female with unknown medical history who on 09-JUN-2009 mid morning was vaccinated with the first dose of GARDASIL. On 10-JUN-2009 around 2:00 AM the patient started to feel nauseous, had vomited and had flu like symptoms. On 11-JUN-2009 around 5:00 AM the patient continued to feel sick and was also experiencing abdominal pain, diarrhea, chest pain, had a fever of 100.7F and her boyfriend who is an Emergency medical technician took her blood pressure which was low around the 70's. The patient had called physician for medical attention. It was unknown if the patient was going to receive the rest of the series. At the time of the report, the patient's status was unknown. Additional information has been requested.
Severe shaking for three hours, severe headache, nausea, dizziness, couldn't walk cause I was so sick, extremely weakness, loss of taste, fever
This case was reported in a literature article and described the occurrence of uveitis in a 28-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). Concurrent medications included Prednisolone and Diclofenac. On an unspecified date the subject received 1st dose of Hepatitis B (unknown). Fifteen days  after vaccination with Hepatitis B, the subject experienced uveitis, meningitis, lymphadenopathy, influenza like symptoms and headache. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
3rd dose has not been administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (received first dose on 10th December 2021) and Engerix B (received second dose on 13th January 2022 batch number:4EA77 expiry date:11-Sep-2022).   On an unknown date, the patient did not receive the 3rd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 17-Aug-2022 Reporter's Comments: A Pharmacist reported that a female patient received the first dose of Engerix B on 10th December 2021, and the second dose on 13th January 2022 and the 3rd dose had not been administered yet.  The reporter denied to follow-up. The Vaccine Administration Facility is the same as Primary Reporter. Additional Supportive Information: Till the time of reporting, the patient had not received the 3rd dose of Engerix B, which led to incomplete course of vaccination.
Flu like symptoms Muscle aches and fatigue, headache Soreness at injection site. Self management with advil and rest. Had same symptoms after the initial shot in August of 2018. Recovered in 2 to 3 days.
Hives, Swelling.  Was given prednisone.  Swelling and hives currently ongoing.
received her first dose in April 2018 and the second dose on 5/2/2021.; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in April 2018).   On 2nd May 2021, the patient received the 2nd dose of Shingrix. On 2nd May 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional information was provided follows:  The patient received Shingrix more than recommended interval, which led to lengthening of vaccination schedule. The reporter did not consent to follow up.